Immunovant, Inc. (IMVT)

Last Closing Price: 26.72 (2026-03-05)

Combined Ratio (Quarterly)

Combined Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The combined ratio is calculated by taking the sum of incurred losses and expenses and then dividing them by earned premium. Calculated as: Total Operating Expenses / Net Premiums Earned

Immunovant, Inc. (IMVT) Combined Ratio data is not available.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
--
$-110.64M
--
--
$114.36M
$-114.36M
$5.28M
$-109.08M
$-109.08M
$-110.64M
$-110.64M
$-110.64M
$-110.64M
$-114.36M
$-114.26M
181.51M
181.51M
$-0.61
$-0.61
Balance Sheet Financials
$1.04B
$0.53M
$9.45M
$1.05B
$66.26M
--
--
$66.26M
$986.13M
$986.13M
$986.13M
203.32M
Cash Flow Statement Financials
$-312.25M
--
$592.12M
$713.97M
$994.52M
$280.55M
$44.58M
--
--
Fundamental Metrics & Ratios
15.74
--
--
--
--
--
--
--
--
--
--
$-312.25M
--
--
Combined Ratio
--
--
--
--
--
-11.22%
-11.22%
-10.51%
-11.22%
$4.85
$-1.72
$-1.72